Xiaofeng Zhou, (周晓峰) associate professor, Center for Molecular Biology of Oral Diseases, University of Illinois at Chicago College of Dentistry, is an internationally known oral cancer researcher.
His primary research interest is to utilize molecular genetics and bioinformatics technologies to develop novel diagnostic tools and to gain a better understanding of human diseases such as head and neck/oral cancer. His research is focused on the genetic mapping of disease genes and/or consistent genomic alterations that are associated with the development and progression of oral cancer.
Zhou previously had been an assistant professor of oral biology at the University of California, Los Angeles (UCLA) School of Dentistry, and also was a member of UCLA’s Jonsson Comprehensive Cancer Center and the university’s Dental Research Institute. He holds a BS in biochemistry and microbiology from Hangzhou University in China; a PhD in biochemistry and a postdoctorate training in human genetics from Boston University; and an MS in software engineering from Brandeis University.
Zhou has published more than 80 journal articles, review articles, and book chapters, and holds three National Institutes of Health grant research projects.
Zhou is also a visiting professor at Sun Yat-sen University, China.
The Stanford University School of Medicine is the medical school of Stanford University and is located in Stanford, California, United States. It traces its roots to the Medical Department of the University of the Pacific, founded in San Francisco in 1858. This medical institution, then called Cooper Medical College, was acquired by Stanford in 1908. The medical school moved to the Stanford campus near Palo Alto, California, in 1959.
Marco A. Marra is a Distinguished Scientist and Director of Canada's Michael Smith Genome Sciences Centre at the BC Cancer Research Centre and Professor of Medical Genetics at the University of British Columbia (UBC). He also serves as UBC Canada Research Chair in Genome Science for the Canadian Institutes of Health Research and is an inductee in the Canadian Medical Hall of Fame. Marra has been instrumental in bringing genome science to Canada by demonstrating the pivotal role that genomics can play in human health and disease research.
The Texas A&M Institute of Biosciences and Technology (IBT), a component of Texas A&M Health, and The Texas A&M University System, is located in the world's largest medical center, the Texas Medical Center, in Houston, Texas. The institute provides a bridge between Texas A&M University System scientists and other institutions' researchers working in the Texas Medical Center and the biomedical and biotechnology research community in Houston. It emphasizes collaboration between member scientists and others working in all the fields of the biosciences and biotechnology. IBT encourages its scientists to transfer discoveries made in their laboratories to the clinic and marketplace.
Rick Antonius Kittles is an American biologist specializing in human genetics and a Senior Vice President for Research at the Morehouse School of Medicine. He is of African-American ancestry, and achieved renown in the 1990s for his pioneering work in tracing the ancestry of African Americans via DNA testing.
The College of Natural Science (NatSci) at Michigan State University is home to 27 departments and programs in the biological, physical and mathematical sciences.
The Dr. Paul Janssen Award for Biomedical Research is given annually by Johnson & Johnson to honor the work of an active scientist in academia, industry or a scientific institute in the field of biomedical research. It was established in 2004 and perpetuates the memory of Paul Janssen, the founder of Janssen Pharmaceutica, a Johnson & Johnson subsidiary.
Kenneth Breslauer is the Linus C. Pauling Distinguished Professor of Chemistry and Chemical Biology at Rutgers University. He is the Founding Dean of the Division of Life Sciences and served as vice president for Health Science Partnerships. Kenneth Breslauer's research focuses on defining and characterizing the molecular forces that control communication between biological molecules, particularly those interactions that modulate and control gene expression, DNA damage repair, mutagenesis, and drug binding. Breslauer arrived at the university as an assistant professor in 1974.
Masayoshi Yamaguchi is a biomedical scientist and researcher, most known for his contributions to biomedical fields including biochemistry, endocrinology, metabolism, nutrition, pharmacology, and toxicology. He is a full professor in the Cancer Biology Program at the University of Hawaii Cancer Center, University of Hawaii at Manoa (UH), focusing on research in bone and calcium endocrinology, metabolism, cell calcium signaling, gene regulation, dietary prevention of osteoporosis, carcinogenesis, and cancer therapy.
Alan Ashworth, FRS is a British molecular biologist, noted for his work on genes involved in cancer susceptibility. He is currently the President of the UCSF Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco, a multidisciplinary research and clinical care organisation that is one of the largest cancer centres in the Western United States. He was previously CEO of the Institute of Cancer Research (ICR) in London.
Manchanahalli Rangaswamy Satyanarayana Rao was an Indian scientist. He was awarded the fourth-highest civilian award, the Padma Shri, for Science and Engineering in 2010. From 2003 to 2013 he was president of Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) in Bangalore, India.
Ming-Ming Zhou is an American scientist whose specification is structural and chemical biology, NMR spectroscopy, and drug design. He is the Dr. Harold and Golden Lamport Professor and Chairman of the Department of Pharmacological Sciences. He is also the co-director of the Drug Discovery Institute at the Icahn School of Medicine at Mount Sinai and Mount Sinai Health System in New York City, as well as Professor of Sciences. Zhou is an elected fellow of the American Association for the Advancement of Science.
Stephen Joseph Elledge is an American geneticist. He is the current Gregor Mendel Professor of Genetics and of Medicine at the Department of Genetics of Harvard Medical School and in the Division of Genetics of the Brigham and Women's Hospital. His research is focused on the genetic and molecular mechanisms of eukaryotic response to DNA damage and is known as the discoverer of the DNA damage response (DDR).
No-Hee Park is a distinguished professor of dentistry and dean emeritus at the School of Dentistry at the University of California, Los Angeles. He is also a researcher and scientist in the field of oral and craniofacial research. He has more than 170 scientific publications, nine invited review articles, nine book chapters and 180 abstracts for national and international scientific presentations.
Eliezer Huberman is an American scietnist who is the founder, scientific director, and CEO of Novadrug LLC, a Chicago-based pharmaceutical firm. He is currently an adjunct professor in the College of Pharmacy at the University of Illinois.
Sarah Spiegel is professor and chair of the Department of Biochemistry and Molecular Biology at Virginia Commonwealth University (VCU). In the mid-1990s she discovered the sphingosine-1-phosphate (S1P) molecule, a lipid which has been identified as a signaler for the spread of cancer, inflammation, and cardiovascular disease. Her research continues to focus on S1P.
Institute for Medical Research, Israel-Canada (IMRIC) is a research institute affiliated with the Faculty of Medicine of the Hebrew University of Jerusalem.
Michael C. Ostrowski is an American cancer biologist and geneticist currently is the WH Folk Endowed Professor at Hollings Cancer Center, Medical University of South Carolina and an Elected Fellow at the American Association for the Advancement of Science. His interests are cancer cells and genes.
Georgia Mae Dunston is an American geneticist who is professor of human immunogenetics at Howard University and founding director of the National Human Genome Center at Howard University.
Michael McClelland is an academic. He is a professor of microbiology and genetics at the University of California, Irvine.
Karen J. Colley is an American glycobiologist and academic administrator serving as the provost of the University of Illinois Chicago since 2023. She is a professor of biochemistry and molecular genetics and the editor-in-chief of Glycobiology.